Kirsty Houslay

Title: Kirsty Houslay: Innovator in Cytokine Modulation

Introduction

Kirsty Houslay is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunology, particularly in the development of therapies targeting cytokine activity. With a total of 2 patents to her name, her work is paving the way for advancements in treating immune and inflammatory disorders.

Latest Patents

Houslay's latest patents include innovations related to polynucleotides encoding IL-33 antibodies. The first patent provides isolated IL-33 proteins, active fragments, and antibodies against IL-33 proteins. It also outlines methods for modulating cytokine activity, which can be crucial for treating various immune and inflammatory disorders. The second patent further explores IL-33 forms, including mutated variants, and details antibodies, assays, and methods for their application in therapeutic contexts.

Career Highlights

Kirsty Houslay is currently associated with Medimmune Limited, where she continues her research and development efforts. Her work has garnered attention for its potential impact on therapeutic strategies in immunology.

Collaborations

Houslay collaborates with notable colleagues, including Emma Suzanne Cohen and David C Lowe, enhancing the innovative environment in which she works.

Conclusion

Kirsty Houslay's contributions to the field of immunology through her patents and collaborative efforts highlight her role as a key innovator. Her work is instrumental in advancing treatments for immune and inflammatory disorders.